Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Surveillance for recurrent bladder cancer using a point-of-care proteomic assay

Article Abstract:

Patients with a history of bladder cancer have recurrences, so rigorous surveillance is necessary. The investigation is conducted whether a point-of-care proteomic test that measures the nuclear matrix protein NMP22 in voided urine could improve the detection of recurrence during monitoring of patients with a history of bladder cancer and it is found that the noninvasive point-of-care assay for elevated urinary NMP22 protein can increase the ability to detect recurrent bladder cancer.

Author: Grossman, H. Barton, Yu Shen, Soloway, Mark, Katz, Giora, Stein, Barry, Kassabian, Vahan
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Care and treatment, Risk factors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Detection of bladder cancer using a point-of-care proteomic assay

Article Abstract:

A study was conducted to investigate whether a point-of-care proteomic test that measures the nuclear matrix protein NMP22 in voided urine could enhance detection of malignancy in patients with risk factors or symptoms of bladder cancer. It was concluded that the noninvasive point-of-care assay for elevated urinary NMP22 protein could increase the accuracy of cystoscopy.

Author: Grossman, H. Barton, Berger, Yitzhak, Messing, Edward, Yu Shen, Soloway, Mark, Tomera, Kevin, Katz, Giora
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Science & research, Research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Relevance of urine telomerase in the diagnosis of bladder cancer

Article Abstract:

A relatively simple, inexpensive, and accurate test that measures telomerase activity in voided urine to apply to large-scale screening programs for bladder detection is developed. The test represents a potentially useful noninvasive diagnostic innovation for bladder cancer detection in high-risk groups such as habitual smokers or in symptomatic patients.

Author: Sanchini, Maria Aurora, Gunelli, Roberta, Nanni, Oriana, Bravaccini, Sara, Fabbri, Carla, Calistri, Daniele, Ravaioli, Dino, Bercovich, Eduard, Sermasi, Alice
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Methods, Usage, Telomerase, Urine, Urinalysis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Diagnosis, Bladder cancer
Similar abstracts:
  • Abstracts: Seeing the forest for the trees. Canada tops cancer research impact list
  • Abstracts: Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future. Introduction
  • Abstracts: Effect light energy on peroxide tooth bleaching. Pulling teeth into the genomics era
  • Abstracts: Government plans on HAIs do not address the cause of the problem. Resources to aid further learning about infection control
  • Abstracts: Multiple nuchal cord entanglements and intrapartum complications. Pharmacotherapy for pregnant women with addictions
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.